Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-663958x
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-663958x
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-5250557x
20%
—
—
Never
—
5 Years
Score—
Net Growth-5250557x
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Reviva Pharmaceuticals Holdings Inc. fundamental performance
Across Reviva Pharmaceuticals Holdings Inc.'s full reported history, from 2018 to 2025, net income went from -$ 1M to -$ 19.86T. Revenue increased in 0% of the years measured; net income in 29%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.46 | — |
1 Year2025-08-12 | $ 9.20 | -94.99% |
5 Years2021-08-12 | $ 69.40 | -99.34% |
All Time2018-10-18 | $ 194.20 | -99.76% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2018-10-18 |
|---|---|---|---|---|
| Price | $ 0.46 | $ 9.20 | $ 69.40 | $ 194.20 |
| Return | — | -94.99% | -99.34% | -99.76% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 0.00 | -$ 19.86T | $ 14.43T |
| 2024 | $ 0.00 | -$ 29M | $ 13M |
| 2023 | $ 0.00 | -$ 39M | $ 23M |
| 2022 | $ 0.00 | -$ 24M | $ 18M |
| 2021 | $ 0.00 | -$ 8M | $ 29M |
| 2020 | $ 0.00 | -$ 3M | $ 8M |
| 2019 | $ 0.00 | -$ 846.83K | $ 193.00 |
| IPO2018 | -$ 1M | $ 65M |
Explore beyond RVPH
You're looking at Reviva Pharmaceuticals Holdings Inc.. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
